1. Home
  2. GLDD vs AKBA Comparison

GLDD vs AKBA Comparison

Compare GLDD & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Great Lakes Dredge & Dock Corporation

GLDD

Great Lakes Dredge & Dock Corporation

HOLD

Current Price

$16.96

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.43

Market Cap

729.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLDD
AKBA
Founded
1890
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
729.1M
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
GLDD
AKBA
Price
$16.96
$1.43
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$17.00
$5.75
AVG Volume (30 Days)
1.5M
2.6M
Earning Date
05-26-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
28.57
93.94
EPS
1.08
N/A
Revenue
$702,503,000.00
N/A
Revenue This Year
$3.79
$1.84
Revenue Next Year
$9.01
N/A
P/E Ratio
$15.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.51
$1.14
52 Week High
$16.99
$4.08

Technical Indicators

Market Signals
Indicator
GLDD
AKBA
Relative Strength Index (RSI) 67.65 56.36
Support Level $14.60 $1.16
Resistance Level $16.99 $1.52
Average True Range (ATR) 0.04 0.07
MACD -0.09 0.03
Stochastic Oscillator 80.00 67.89

Price Performance

Historical Comparison
GLDD
AKBA

About GLDD Great Lakes Dredge & Dock Corporation

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: